Aurobindo Pharma share news, announcements and annual reports
NSE: AUROPHARMABSE: 524804Pharmaceuticals & BiotechnologyMid Cap
Aurobindo Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, Jul 2000 on NSE
Last close ₹1,659.90up ₹15.10 (0.92%)BSE ₹1,655.00
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,644.80.
29 Oct: open ₹1,643.00, high ₹1,659.90, low ₹1,635.10
52-week range of traded prices to 29 Oct 2026
₹1,091.20Low, 30 Oct 2025₹1,740.00High, 24 Sep 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and dividend. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹95,507 Cr138th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 25.73
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.52
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.20
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,10,88155.8% delivered
Aurobindo Pharma orders, deals and press releases
463 filed, newest first. Page 9 of 10.
Dec 2008
17 Dec · Business
Press release dated December 17, 2008, titled "Aurobindo Pharma receives tentative approval for its New Drug Application (NDA) Efavirenz Tablets 100mg". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Dec · Business
Press release dated December 05, 2008, titled, "Aurobindo Pharma receives tentative approval for Perindopril Erbumine Tablets and Escitalopram Oxalate Oral Solution". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2008
7 Nov · Business
Press release dated November 07, 2008, titled, "Aurobindo Pharma receives final approval for Sertraline Hydrochloride Oral Concentrate". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2008
31 Oct · Business
Press release dated October 31 2008, with respect to unaudited financial results for the quarter ended September 30, 2008. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 Oct · Business
Press release dated October 13, 2008, titled "Aurobindo Pharma receives final approval for Risperidone Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Oct · Business
Press release dated October 10, 2008, titled "Aurobindo Pharma receives final approval for Fluconazole Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Oct · Business
Press release dated October 10, 2008, titled "Aurobindo Pharma receives final approval for Cyclobenzaprine Hydrochloride Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2008
25 Sep · Business
Press release dated September 25, 2008, titled "Aurobindo Pharma receive final approval for Didanosine Delayed Release Capsules". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Sep · Business
Press release dated , September 23, 2008, titled "Aurobindo Pharma awarded the INDIASTAR 2008 for Packaging Excellence". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Sep · Business
Press release dated September 17, 2008, titled "Aurobindo Pharma receives tentative approval for its New Drug Application (NDA) Abacavir Sulfate 60mg Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Sep · Business
Press release dated September 08, 2008, titled " Aurobindo Pharma receives tentative approval for Abacavir Sulfate / Lamivudine Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2008
21 Aug · Business
Press release dated August 21, 2008, titled " Aurobindo Pharma receives tentative approval for Losartan Potassium tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Aug · Business
Press release dated August 11, 2008, titled " Aurobindo Pharma receives final approval for Cefazolin for Injection USP". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Aug · Business
Press release dated August 05, 2008, titled " Aurobindo Pharma receives final approval for Alendronate Sodium Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.1 Aug · Business
Press release dated August 01, 2008, titled " Aurobindo Pharma's Sterile Injectable Formulation line of Unit VIB, India has received the final approval for Ceftriaxone for Injection USP by USFDA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
30 Jul · Business
Press release dated July 30 2008, with respect to unaudited financial results for the quarter ended June 30, 2008. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Jul · Business
Press release dated July 16, 2008, titled "Fitch Assigns 'A+(ind)/F1+(ind)' to Aurobindo Pharma's Bank Loan Facilities". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2008
18 Jun · Business
Press release dated June 18, 2008, titled "Aurobindo records consolidated Total Income of Rs 2530 crores and Net Profit of Rs.238 crores. Formulation business constitutes 39.4% of the net sales". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Jun · Business
Press release dated June 10, 2008, titled "Aurobindo Pharma receives final approval for Zaleplon Capsules". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2008
27 May · Business
Press release dated May 27, 2008, titled "Aurobindo Pharma receives final approval for Benazepril Hydrochloride tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 May · Business
Press release dated May 12, 2008, titled "Aurobindo Pharma receives nine product approvals from MCC- South Africa". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Mar 2008
24 Mar · Business
Press release dated March 24, 2008, titled "Aurobindo expands in Europe". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2008
1 Feb · Business
Press release dated February 01, 2008, titled "Aurobindo Pharma receives tentative approval for Sumatriptan Succinate Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
31 Jan · Business
Press release dated January 31, 2008, titled "Aurobindo Pharma receives Rs.70 crores ARV supply contract by NACO". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.30 Jan · Business
Press release dated January 30, 2008, titled "Q3 2007-08 Financial Results; Total Income Rs. 549.42 Crs; Net Profit Rs. 55.25 Crs". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Jan · Business
Press release dated January 21, 2008, titled "Aurobindo Pharma receives approval for Cefdinir Capsules". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2007
22 Nov · Business
Press release dated November 22, 2007, titled "Aurobindo Pharma receives five product approvals from USFDA including two Paragraph IV products". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
31 Oct · Business
Press release dated October 31, 2007, titled "Aurobindo Pharma declares Q2 2007-08 results". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Oct · Business
Press release dated October 05, 2007, titled "Aurobindo Pharma receives UK-MHRA clearance for Unit XI". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2007
13 Sep · Business
Press release dated September 13, 2007, titled "Aurobindo Pharma receives UK-MHRA clearance for Unit I". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Sep · Business
Press release dated September 07, 2007, titled "Aurobindo Pharma receives UK-MHRA clearance for Unit VIII". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Sep · Business
Press release dated September 06, 2007, titled "Aurobindo Pharma receives EIR for Sterile Drug Formulation Facility from US FDA". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
31 Jul · Business
Press release dated July 31, 2007, with respect to Unaudited Financial Results for the quarter ended June 30, 2007. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Jul · Business
Press release dated July 19, 2007, titled "Aurobindo receives approval from USFDA for Amlodipine Besylate Tablets". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 Jul · Business
Press release dated July 03, 2007, titled "Aurobindo received 46th ANDA approval from USFDA for Terbinafine HCL Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.2 Jul · Business
Press release dated June 30, 2007, titled "Aurobindo records revenues of Rs.23 billions with multifold growth in earnings". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2007
26 Jun · Business
The Hon'ble court of Andhra Pradesh has approved the Scheme of Arrangement for the merger of APL Life Sciences Limited (APL Life) and Senor Organics Private Limited (Senor) into Aurobindo Pharma Limited and the utilisation of share premium account of the Company. Further, no shares would be issued by the Company in consideration for the merger as both APL Life and Senor are wholly owned subsidiary companies. KPMG India Private Limited has assisted in the process of merger26 Jun · Business
Press release dated June 26, 2007, titled "Aurobindo receives Tentative approval for Quinapril Hydrochloride and Hydrochlorothiazide Tablets from USFDA". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Jun · Business
Press release dated June 19, 2007, titled "Aurobindo received Zidovudine approval from MCC South Africa". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Jun · Business
Press release dated June 18, 2007, titled "Aurobindo receives Tenth approval from MCC South Africa". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Jun · Business
Press release dated June 15, 2007, titled "Aurobindo gets USFDA Approval for Trandolapril Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Jun · Business
Press release dated June 15, 2007, titled "Aurobindo receives USFDA Approval for Cefpodoxime proxetil Tablets". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.13 Jun · Business
Press release dated June 13, 2007, titled "Aurobindo Pharma Unveils New Corporate Identity". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.6 Jun · Business
Press release dated June 05, 2007, titled "Aurobindo receives USFDA approval for its Ciprofloxacin". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Jun · Business
Press release dated June 05, 2007, titled "Aurobindo gets USFDA Approval for its Cefpodoxime oral suspension". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2007
29 May · Business
Press release dated May 29, 2007, titled "Aurobindo gets USFDA Approval for its Cefprozil Tablets". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 May · Business
Press release dated May 07, 2007, titled "Aurobindo receives USFDA approval for its Zolpidem". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 May · Business
Press Release dated May 01, 2007 titled as "Aurobindo receives Ninth approval from MCC South Africa". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2007
26 Apr · Business
Press release dated April 26, 2007, titled "Aurobindo receives Eighth approval from MCC South Africa". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Apr · Business
Press release dated April 04, 2007, titled "MEB Netherlands approves Lisinopril Tablets of Aurobindo". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.